From: Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
Reduction in antibiotic consumption (part 4a) | |
• Reduction of 1% or more in total antibiotic consumption against the baseline | |
• Reduction of 1% or more in carbapenem against the baseline | |
• Reduction of 1% or more in piperacillin-tazobactam against the baseline | |
Empiric review of antibiotic prescriptions (part 4b) | |
• Percentage of antibiotic prescriptions reviewed within 72 h | |
Quarter 1 | Perform an empiric review for at least 25% of cases in the sample |
Quarter 2 | Perform an empiric review for at least 50% of cases in the sample |
Quarter 3 | Perform an empiric review for at least 75% of cases in the sample |
Quarter 4 | Perform an empiric review for at least 90% of cases in the sample |